Morgan Stanley 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-08 6:26 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | MORGAN STANLEY MS | 596,564 3.500% | 188 (+0.03%) | Filing |
| 2026-02-12 1:21 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | MORGAN STANLEY MS | 596,376 9.600% | 596,376 (New Position) | Filing |